- Medtech Insight
- >>Geography
Device Debut: Zimmer Biomet's Sidus Stemless Shoulder Will Take On Wright's Simpliciti
US FDA cleared the Sidus total shoulder arthroplasty system for patients with "good bone stock" who have osteoarthritis, posttraumatic arthrosis, focal avascular necrosis of the humeral head, or a previous shoulder surgery that does not compromise the fixation. The company is planning to launch it in the US by the end of the quarter.
Zimmer Biomet Holdings Inc., the leader in the US shoulder replacement market, will soon compete with Wright Medical Group NV in the bone-sparing shoulder segment of the US orthopedics market.
US FDA 510(k)-clearedZimmer Biomet Holdings Inc.'s Sidus stem-free shoulder system for total shoulder arthroplasty, and the company plans to launch it in the US market within the first...